The Freedom of Information Team
Information Governance Team Office
1st Floor Haylock House
Kettering Venture Park
Kettering NN15 6EY
0300 0111133 (voicemail only) * foi@nhft.nhs.uk
26 May 2022
wendy micklewright Sent by email only to:
wmicklewright@yahoo.co.uk
Dear Requester,
Freedom of Information Act 2000 request: FOI0522008
With reference to your request for information made under section 1(1) of the Freedom of Information Act: we set out below your request together with the Trust’s response:
You submitted:
A Freedom on Information request regarding Electro Convulsive Therapy (ECT); Serious Incidents; Restraint; Seclusion & Medication Errors.
The Trust has addressed each topic in turn and lists below your questions together with in-line responses in emboldened italics.
A) Please provide ECT information under the FOI act to the following questions: -
1.Please supply patient’s information ECT leaflet. See attachment ‘RCPysch ECT Information March 2022’
2.Please supply patient ECT consent form See attachment ‘ECT consent form’
3.Please supply any ECT reports/investigations n/a
4.How many ECT in 2021? 12 patients treated
5.What proportion of patients were men/women? 16.7% male, 83.3% female
6.How old were they? 18-85
7.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? Not a mandatory field of capture therefore unable to report 8.How many were receiving ECT for the first time? 9
9.How many patients consented to ECT? All patients are consented prior to the procedure; where a patient is under Section and does not have capacity, a MCA capacity is completed by the treating clinician.
10.How many ECT complaints were investigated outside the NHS and CCG? None received
11.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
12.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
13.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
14.How many patients have suffered complications during and after ECT and what were those complications? None, each patient receives an anaesthetic review at the start of ECT and is seen by their Responsible Clinician /Consultant after every two sessions.
15.Have there been any formal complaints from patients/relatives about ECT? No
16.If so, what was their concerns? n/a
17.How many patients report memory loss/loss of cognitive function? Short-term memory impairment is a recognised side effect of ECT. No patients reported this as a long-term side effect
18.What tests are used to assess memory loss/loss of cognitive function? MOCA and Hamilton prior to commencement of ECT and thereafter at treatments 4, 8 and 12.
19.Have MRI or CT scans been used before and after ECT? MRI and CT scans are not routinely undertaken at this Trust
20.If so, what was the conclusion? n/a
21.How does the Trust plan to prevent ECT in the future? The Trust has no such plans since it considers ECT a valuable treatment; around 70% of those suffering from psychiatric disorders that undergo the treatment, achieve improvement and/or subsequent recovery
B) Please provide SERIOUS INCIDENT information under the FOI act to the following questions: -
1.Please supply any serious incident reports/investigations? These are not routinely made public owing the sensitive nature and potentially identifiable content
2.How many SERIOUS INCIDENT REPORTS in 2021? 30 investigations were declared
3.What proportion of patients were men/women? 50% male, 37% female, 13% not specified
4.How old were they? Age range: male – 40-94; female – 15-86
5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? Not a mandatory field of capture therefore unable to report
6.How many SERIOUS INCIDENT REPORTS were investigated outside the NHS and CCG? n/a
7.How many patients died during or 1 month after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
8.How many patients died within 6 months after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
9.How many patients died by suicide within 6 months of receiving SERIOUS INCIDENT REPORTS (whether or not SERIOUS INCIDENT REPORTS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
10.How many patients have suffered complications during and after SERIOUS INCIDENT REPORTS and what were those complications? There have been no recorded complications arising from the serious incidents declared
11.Have there been any formal complaints from patients/relatives about SERIOUS INCIDENT REPORTS? There has been one complaint about incident investigation
12.If so, what was their concerns? Around the manner in which the investigation was conducted
13.How does the Trust plan to prevent SERIOUS INCIDENTS in the future? Please refer to the Trust’s Incident Policy.
C) Please provide RESTRAINTS information under the FOI act to the following questions: -
1.Please supply any Restraints/investigations? The Trust has not had any investigations regarding its use of restraint in the period 2021-22
2.How many RESTRAINTS in 2021? 1313
3.What proportion of patients were men/women? 42% male; 58% female
4.How old were they? Under 19 (23%); 20-59 (59%); over 60 (18%)
5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? Not a mandatory field of capture therefore unable to report 6.How many RESTRAINTS were investigated outside the NHS and CCG? None
7.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
8.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
9.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
10.How many patients have suffered complications during and after RESTRAINTS and what were those complications? Nil recorded
11.Have there been any formal complaints from patients/relatives about RESTRAINTS? The Trust has recorded four complaints around restraints
12.If so, what was their concerns? Level of restraint was excessive in relation to physical proportions of patient
13.Are counts of forced injections available? 123
14.How does the Trust plan to reduce restraints in the future? Please refer to the Trust website The Difference We’re Making: Reducing Restraint in Inpatient Mental Health Settings
D) Please provide SECLUSION information under the FOI act to the following questions: -
1.Please supply any SECLUSION reports/investigations There have been no investigations pertaining to seclusions during the period 2021-2022.
2.How many SECLUSIONS in 2021? 430
3.What proportion of patients were men/women? 56% male; 44% female
4.How old were they? Under 19 (5%); 20-59 (89%); 60+ (6%)
5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? Not a mandatory field of capture therefore unable to report
6.How many SECLUSIONS were investigated outside the NHS and CCG? none
7.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
8.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
9.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the
Coroner
10.How many patients have suffered complications during and after SECLUSION and what were those complications? Northamptonshire Healthcare NHS Foundation Trust does not capture this information in a reportable format.
11.Have there been any formal complaints from patients/relatives about SECLUSION? The Trust has recorded two complaints around seclusion.
12.If so, what was their concerns? Inadequate hydration / nutrition and personal care provided during the period
13.How does the Trust plan to reduce SECLUSIONS in the future? Please see the Trust’s public-facing website for our CLP007 Seclusion Policy
E) Please provide MEDICATION ERRORS information under the FOI act to the following questions: -
1.Please supply any MEDICATION ERRORS reports/investigations none recorded
2.How many MEDICATION ERRORS in 2021? 893
3.What proportion of patients were men/women? circa 50% male ; 40% female (data not captured in 10% of records)
4.How old were they? Under 19 (10%); 20-59 (33%); over 60 (43%) - data not captured in 14% of records
5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? Not a mandatory field of capture therefore unable to report 6.How many MEDICATION ERRORS were investigated outside the NHS and CCG? none
7.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
8.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
9.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)? This information is not recorded in a reportable format at Trust level - enquiries regarding deaths should be directed to the Coroner
10.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications? None recorded
11.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS? the Trust has recorded two complaints regarding medication errors
12.If so, what was their concerns? Medications not administered as prescribed
13.How does the Trust plan to prevent MEDICATION ERRORS in the future? The Trust has a multidisciplinary Medicine’s Safety Group that monitors all medication incidents ( both actual incidents and near misses) and shares learning from these incident reports across the organisation, advising on changes to practice and policy should these be required. Ongoing implementation of Electronic Prescribing and Medicines
Administration (EPMA) is part of the Trust’s strategy to continuously improve medicines safety.
This concludes our response to your request for information. If you are unhappy with the reply, please forward your concerns to the address below to request an Internal Review detailing the reasons for your dissatisfaction and these will be addressed accordingly.
Head of Clinical Systems and Governance
NHFT Information Governance Team Office
1st Floor Haylock House, Kettering Venture Park
Kettering
NN15 6EY
Alternatively, you may email your request to dpo@nhft.nhs.uk
If you are not content with the outcome of your complaint, you may apply directly to the Information Commissioner for a decision. Generally, the Information Commissioner cannot make a decision unless you have exhausted the complaints procedure provided by the Trust. The Information Commissioner can be contacted at:
The Information Commissioner's Office
Wycliffe House Water Lane
Wilmslow
SK9 5AF
Yours faithfully,
The Freedom of Information Team
Northamptonshire Healthcare NHS Foundation Trust
Email: foi@nhft.nhs.uk | Web: Northamptonshire Healthcare Home
Information Governance Team Office
1st Floor Haylock House | Kettering Venture Park | Kettering | NN15 6EY